Skip to main content
OpenTrials

Clinical trial condition

Colonic Diseases

Explore clinical trials studying Colonic Diseases. Study availability and eligibility vary by location and protocol.

7,489 public trials 1,474 recruiting studies
Refine in advanced search Browse all conditions

Colonic Diseases trial results

Active, Not Recruiting

Testing the Combination of Two Anti-cancer Drugs, DS-8201a and AZD6738, for The Treatment of Advanced Solid Tumors Expressing the HER2 Protein or Gene, The DASH Trial

NCT04704661

Conditions
Advanced Breast Carcinoma, Advanced Colon Carcinoma, Advanced Colorectal Carcinoma, +80 more
Locations
  • UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care Irvine, California, United States
  • Los Angeles General Medical Center Los Angeles, California, United States
  • USC / Norris Comprehensive Cancer Center Los Angeles, California, United States
  • UC Irvine Health/Chao Family Comprehensive Cancer Center Orange, California, United States
View all 23 locations
View Trial Details
Active, Not Recruiting

Testing a Combination of Vaccines for Cancer Prevention in Lynch Syndrome

NCT05419011

Conditions
Colonic Diseases, Colorectal Carcinoma, Colorectal Neoplasm, +18 more
Locations
  • Mayo Clinic Hospital in Arizona Phoenix, Arizona, United States
  • University of Arizona Cancer Center - Prevention Research Clinic Tucson, Arizona, United States
  • UCSF Medical Center-Parnassus San Francisco, California, United States
  • UCHealth University of Colorado Hospital Aurora, Colorado, United States
View all 14 locations
View Trial Details
Active, Not Recruiting

Study of Onvansertib in Combination With FOLFIRI and Bevacizumab or FOLFOX and Bevacizumab Versus FOLFIRI and Bevacizumab or FOLFOX and Bevacizumab for First-Line Treatment of Metastatic Colorectal Cancer in Adult Participants With a KRAS or NRAS Mutation

NCT06106308

Conditions
CRC, Colonic Diseases, Colorectal Neoplasms, +11 more
Locations
  • Mayo Clinic - Arizona Phoenix, Arizona, United States
  • The University of Arizona Cancer Center Tucson, Arizona, United States
  • St. Bernards Medical Center Jonesboro, Arkansas, United States
  • Highlands Oncology Group Springdale, Arkansas, United States
View all 41 locations
View Trial Details
Active, Not Recruiting

Platform Study of JDQ443 in Combinations in Patients With Advanced Solid Tumors Harboring the KRAS G12C Mutation

NCT05358249

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +25 more
Locations
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
  • NYU School of Medicine New York, United States
  • Novartis Investigative Site Leuven, Belgium
View all 13 locations
View Trial Details
Active, Not Recruiting

A Study of Intravenous Vedolizumab Administered Every 4 Weeks in Japanese Participants With Moderate to Severe Ulcerative Colitis or Crohn's Disease

NCT04738942

Conditions
Colitis, Colitis, Ulcerative, Colonic Diseases, +8 more
Locations
  • Ieda Hospital Toyota, Aichi-ken, Japan
  • Hirosaki University Hospital Hirosaki, Aomori, Japan
  • Tsujinaka Hospital Kashiwa, Chiba, Japan
  • Toho University Sakura Medical Center Sakura, Chiba, Japan
View all 20 locations
View Trial Details

Related conditions